Mitchell C. VeDepo

Mitchell C. VeDepo

Auto-generated profile, based on publicly available information

Mitchell C. VeDepo

Department of Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DJDillon K Jarrell
Dillon K Jarrell
EVEthan J. Vanderslice
Ethan J. Vanderslice
MLMallory L. Lennon
Mallory L. Lennon
ALAnne C. Lyons
Anne C. Lyons
MVMitchell C. VeDepo
Mitchell C. VeDepo
JJJeffrey Jacot
Jeffrey Jacot
Fibrin has been used clinically for wound coverings, surgical glues, and cell delivery because of its affordability, cytocompatibility, and ability to modulate angiogenesis and inflammation. However, its rapid degradation rate has limited its usefulness as a scaffold for 3D cell culture and tissue engineering. Previous studies have sought to slow the degradation rate of fibrin with the addition of proteolysis inhibitors or synthetic crosslinkers that require multiple functionalization or polymerization steps. These strategies are difficult to implement in vivo and introduce increased complexity, both of which hinder the use of fibrin in research and medicine. Previously, we demonstrated that additional crosslinking of fibrin gels using bifunctionalized poly(ethylene glycol)-n-hydroxysuccinimide (PEG-NHS) slows the degradation rate of fibrin. In this study, we aimed to further improve the longevity of these PEG-fibrin gels such that they could be used for tissue engineering in vitro or in situ without the need for proteolysis inhibitors. It is well documented that increasing the salinity of fibrin precursor solutions affects the resulting gel morphology. Here, we investigated whether this altered morphology influences the fibrin degradation rate. Increasing the final sodium chloride (NaCl) concentration from 145 mM (physiologic level) to 250 mM resulted in fine, transparent high-salt (HS) fibrin gels that degrade 2–3 times slower than coarse, opaque physiologic-salt (PS) fibrin gels both in vitro (when treated with proteases and when seeded with amniotic fluid stem cells) and in vivo (when injected subcutaneously into mice). Increased salt concentrations did not affect the viability of encapsulated cells, the ability of encapsulated endothelial cells to form rudimentary capillary networks, or the ability of the gels to maintain induced pluripotent stem cells. Finally, when implanted subcutaneously, PS gels degraded completely within one week while HS gels remained stable and maintained viability of seeded dermal fibroblasts. To our knowledge, this is the simplest method reported for the fabrication of fibrin gels with tunable degradation properties and will be useful for implementing fibrin gels in a wide range of research and clinical applications.

1 January 2018 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
MVMitchell VeDepo
Mitchell VeDepo
EBEric Buse
Eric Buse
RQRachael Quinn
Rachael Quinn
RHRichard Hopkins
Richard Hopkins
GCGabriel Converse
Gabriel Converse
The tissue-engineered heart valve may be the ideal valve replacement option but still must overcome challenges in leaflet recellularization. This study sought to investigate the potential for leaflet matrix restoration and repopulation following mononuclear cell seeding and extended periods of bioreactor conditioning. Human aortic heart valves were seeded with mononuclear cells and conditioned in a pulsatile bioreactor for 3 days, 3 weeks, or 6 weeks. The results of this study determined that a mononuclear cell population can be readily localized within the leaflet tissue in as little as 3 days. Furthermore, as extended bioreactor condition continued to the 3- and 6-week time points, the mesenchymal stem cell subfraction proliferated and appeared to become the predominant cell phenotype. This was evident through positive expression of mesenchymal stem cell markers and no expression of mononuclear cell markers observed by immunohistochemistry in the 3- and 6-week groups. In addition, cells in the 3- and 6-week groups exhibited an up-regulation of mesenchymal stem cell–associated genes (THY1, NT5E, and ITGB1) and a down-regulation of mononuclear cell–associated genes (CD14, ICAM1, and PECAM1) compared to the initial seeded cell population. However, repopulation of the leaflet interstitium was less extensive than anticipated. Valves in the 6-week time point also exhibited retracted leaflets. Thus, while the 3-week bioreactor-conditioning period used in this study may hold some promise, a bioreactor-conditioning period of 6 weeks is not a viable option for clinical translation due to the negative impact on valve performance.

24 October 2019 in Cardiovascular Engineering and Technology
Verified
Journal Article
Closed access
PDF file
MVMitchell C. VeDepo
Mitchell C. VeDepo
EBEric E. Buse
Eric E. Buse
APArghya Paul
Arghya Paul
GCGabriel L. Converse
Gabriel L. Converse
RHRichard A. Hopkins
Richard A. Hopkins

30 April 2018 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
MVMitchell VeDepo
Mitchell VeDepo
EBEric Buse
Eric Buse
APArghya Paul
Arghya Paul
RHRichard Hopkins
Richard Hopkins
GCGabriel Converse
Gabriel Converse

9 February 2021 in Cardiovascular Engineering and Technology
Verified
Journal Article
Closed access
PDF file
MVMitchell C. VeDepo
Mitchell C. VeDepo
KFKyra Flores
Kyra Flores
JJJeffrey G. Jacot
Jeffrey G. Jacot

1 June 2024 in Tissue Engineering Part A
Verified
Journal Article
Closed access
DIDora Evelyn Ibarra
Dora Evelyn Ibarra
MJMaggie E. Jewett
Maggie E. Jewett
DJDillon K. Jarrell
Dillon K. Jarrell
APArmando Pinales
Armando Pinales
MVMitchell C. VeDepo
Mitchell C. VeDepo
JJJeffrey Jacot
Jeffrey Jacot
Background: Current treatments for congenital heart defects often require surgery and implantation of a synthetic patch or baffle that becomes a fibrous scar and leads to a high number of reoperations. Previous studies in rats have shown that a pre-vascularized scaffold can integrate into the heart and result in regions of vascularized and muscularized tissue. However, increasing the thickness of this scaffold for use in human hearts requires a method to populate the thick scaffold and mature it under physiologic flow and electrical conditions. Experiment: We developed a bioreactor system that can perfuse up to six 7-mm porous scaffolds with tunable gravity-mediated flow and chronic electrical stimulation. Three polymers which have been reported to be biocompatible were evaluated for effects on the viability of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM). Bioreactor flow and electrical stimulation functions were tested, and the bioreactor was operated for up to 7 days to ensure reliability and lack of leaks in a 37C, humidified incubator. Height and flow relationships were measured for perfusion through an electrospun polycaprolactone (PCL) and gelatin scaffold previously reported by our laboratory. Culture with cells was evaluated by plating human umbilical vein endothelial cells (HUVEC) and human dermal fibroblasts (hDF) on top of the scaffolds in both static and flow conditions for 2,5 and 7 days. As a proof-of concept, scaffolds were cryosectioned and cell infiltration was quantified using immunofluorescence staining. Results: Neither MED610 (Stratasys), Vero (Stratasys), nor FORMLAB materials affected the viability of iPSC derived cardiomyocytes, and MED610 was chosen for manufacture due to familiarity of 3D printing from this material. The generation of electrical field stimulation from 0 to 5 volts and physiological ranges of pump capacities were verified. The relationship between height and flow was calculated for scaffolds with and without cells. Finally, we demonstrated evaluation of cell depth and structure in scaffolds cultured for 2, 5, and 7 days. Conclusion: The gravity-mediated flow bioreactor system we developed can be used as a platform for 3D cell culture particularly designed for perfusing vascularized tissue constructs with electrical stimulation for cardiac maturation.